Ken Griffin Pro Mis Neurosciences Inc. Transaction History
Citadel Advisors LLC
- $550 Billion
- Q2 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Pro Mis Neurosciences Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 63,429 shares of PMN stock, worth $43,131. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63,429Holding current value
$43,131% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PMN
# of Institutions
20Shares Held
8.47MCall Options Held
0Put Options Held
0-
Great Point Partners LLC Greenwich, CT2.65MShares$1.8 Million1.05% of portfolio
-
Armistice Capital, LLC New York, NY2.14MShares$1.45 Million0.02% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L31.9MShares$1.29 Million0.25% of portfolio
-
Ally Bridge Group (Ny) LLC New York, NY1.33MShares$907,4110.92% of portfolio
-
Allostery Investments LP Stamford, CT156KShares$105,8890.97% of portfolio
About ProMIS Neurosciences Inc.
- Ticker PMN
- Exchange OTC
- Description
- ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms t...